Market Research Logo

Genentech Inc - Strategic SWOT Analysis Review

Genentech Inc - Strategic SWOT Analysis Review

provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services.

This up-to-the-minute company report will help you to formulate strategies to drive your business by enabling you to understand your partners, customers and competitors better.

Scope

  • Business description – A detailed description of the company’s operations and business divisions.
  • Corporate strategy – GlobalData’s summarization of the company’s business strategy.
  • SWOT analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
  • Company history – Progression of key events associated with the company.
  • Major products and services – A list of major products, services and brands of the company.
  • Key competitors – A list of key competitors to the company.
  • Key employees – A list of the key executives of the company.
  • Executive biographies – A brief summary of the executives’ employment history.
  • Key operational heads – A list of personnel heading key departments/functions.
  • Important locations and subsidiaries – A list of key locations and subsidiaries of the company, including contact details.
  • Key manufacturing facilities – A list of key manufacturing facilities of the company.
Highlights

Genentech Inc (Genentech), a subsidiary of F. Hoffmann-La Roche Ltd is a biotechnology company that undertakes discovery, development, manufacture and commercialization of medicines for the treatment of patients with serious medical conditions. The company focuses on developing drugs for unmet medical needs in the areas of oncology, immunology, neuroscience, metabolism, infectious disease, ophthalmology and bioinformatics. Some of its products include Rituxan, Avastin, Herceptin, Tarceva, Lucentis, Xolair, Pulmozyme, Activase and others. Genentech research activities focus on areas of cancer, metabolism, immunology, infectious disease and neuroscience. Its clinical development pipeline includes small molecules, monoclonal antibodies, and antibody drug conjugates. Genentech is headquartered in South San Francisco, California, the US.

Genentech Inc Key Recent Developments

Jan 11, 2017: New Drug Formulary Will Help Expedite Use of Agents in Clinical Trials
Jan 09, 2017: Genentech withdraws counterclaim against Exelixis
May 05, 2016: Preliminary results comparing PD-L1 IHC diagnostic assays in lung cancer released
Apr 13, 2016: Stand Up To Cancer Launches “Catalyst,” a New Research Program Supported by Industry

Reasons to Buy
  • Gain key insights into the company for academic or business research purposes. Key elements such as SWOT analysis and corporate strategy are incorporated in the profile to assist your academic or business research needs.
  • Identify potential customers and suppliers with this report’s analysis of the company’s business structure, operations, major products and services and business strategy.
  • Understand and respond to your competitors’ business structure and strategies with GlobalData’s detailed SWOT analysis. In this, the company’s core strengths, weaknesses, opportunities and threats are analyzed, providing you with an up to date objective view of the company.
  • Examine potential investment and acquisition targets with this report’s detailed insight into the company’s strategic, business and operational performance.
Note: Some sections may be missing if data is unavailable for the company.


Section 1 - About the Company
Genentech Inc - Key Facts
Genentech Inc - Key Employees
Genentech Inc - Key Employee Biographies
Genentech Inc - Major Products and Services
Genentech Inc - Pharmaceutical Pipeline Products Data
Genentech Inc, Pipeline Products by Therapy Area
Genentech Inc, Pipeline Products by Development Phase
Genentech Inc - History
Genentech Inc - Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries
Section 2 – Company Analysis
Genentech Inc - Business Description
Genentech Inc - Corporate Strategy
Genentech Inc - SWOT Analysis
SWOT Analysis - Overview
Genentech Inc - Strengths
Genentech Inc - Weaknesses
Genentech Inc - Opportunities
Genentech Inc - Threats
Genentech Inc - Key Competitors
Section 3 – Company’s Lifesciences Financial Deals and Alliances
Genentech Inc, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017
Genentech Inc, Pharmaceuticals & Healthcare, Deals By Type, 2011 to YTD 2017
Genentech Inc, Recent Deals Summary
Section 4 – Company’s Recent Developments
Jan 11, 2017: New Drug Formulary Will Help Expedite Use of Agents in Clinical Trials
Jan 09, 2017: Genentech withdraws counterclaim against Exelixis
May 05, 2016: Preliminary results comparing PD-L1 IHC diagnostic assays in lung cancer released
Apr 13, 2016: Stand Up To Cancer Launches “Catalyst,” a New Research Program Supported by Industry
Section 5 – Appendix
Methodology
About GlobalData
Contact Us
Disclaimer
List of Tables
Genentech Inc, Key Facts
Genentech Inc, Key Employees
Genentech Inc, Key Employee Biographies
Genentech Inc, Major Products and Services
Genentech Inc, Number of Pipeline Products by Therapy Area
Genentech Inc, Number of Pipeline Products by Development Stage
Genentech Inc, History
Genentech Inc, Other Locations
Genentech Inc, Key Competitors
Genentech Inc, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017
Genentech Inc, Pharmaceuticals & Healthcare, Deals By Type, 2011 to YTD 2017
Genentech Inc, Recent Deals Summary
List of Figures
Genentech Inc, Pipeline Products by Therapy Area
Genentech Inc, Pipeline Products by Development Phase
Genentech Inc, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017
Genentech Inc, Pharmaceuticals & Healthcare, Deals by Type, 2011 to YTD 2017

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Share this report